Search results
Mystery Finally Solved? New Discovery Could Explain Long COVID
SciTechDaily· 2 days agoResearchers at UVA Health have uncovered a potential explanation for some of the most puzzling...
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating...
St. Joseph News-Press· 1 day agoThe animals in only the NV-387 treated group survived completely, as previously reported. The...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 10 hours agoClick chemistry is a revolutionary approach to chemical synthesis that won the Nobel Prize in Chemistry 2022.
‘I’m lucky to be alive’ says soldier who was given infected blood transfusion during leg amputation
The Independent via Yahoo News· 1 day agoTens of thousands of people were avoidably infected with HIV and Hepatitis in the worst treatment...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 6 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 5 days agoAlthough the company's revenue declined by 1% year over year to $3.15 billion in the first quarter,...
Does COVID-19 Persist?
MedPage Today· 2 days ago"At the beginning of the pandemic, we never expected to have these discussions about SARS-CoV-2 persistence," said Michael Peluso, MD, MHS, of the...
Invivyd, Inc. (NASDAQ:IVVD) Expected to Earn Q2 2024 Earnings of ($0.46) Per Share
ETF DAILY NEWS· 5 days agoInvivyd, Inc. (NASDAQ:IVVD – Free Report) – HC Wainwright decreased their Q2 2024 earnings per share estimates for shares of Invivyd in a report released on Tuesday, May 14th. HC Wainwright ...
NanoViricides Has Filed its Quarterly Report
The Sacramento Bee· 6 days agoSHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly ...
